Resumo

MESA HERNANDEZ, Eddy et al. Subtenon triamcinolone in the diabetic macular edema. Rev Cubana Oftalmol [online]. 2009, vol.22, n.2, pp. 77-85. ISSN 1561-3070.

INTRODUCTION: Prevalence of diabetic retinopathy is determined by type of diabetes mellitus and the length of development of the disease. Macular edema is the main cause of reduction in visual acuity of the diabetic patient. An early exact diagnosis of the disease together with an adequate treatment is essential to decrease visual disability. The objective of this paper was to evaluate the effectiveness of subtenon triamcinolone as therapy for macular edema in a group of diabetics. METHODS: A prospective descriptive case-control study was conducted. The sample was made up of 30 diabetic patients who were seen at "Dr Miguel Enríquez" clinical and surgical hospital from January to June 2007, with diagnosis of diabetic macular edema, and who met the inclusion criteria. RESULTS: Females prevailed and the 55-65 year age group was the most common. Length of development of the disease was associated with the presence of macular edema; it was evident that this pathology declined and that visual acuity improved after the treatment whereas no serious complications occurred. CONCLUSIONS: The use of triamcinolone acetonide through posterior subtenon way of administration is an alternative for the treatment of macular edema.

Palavras-chave : Diabetic retinopathy; macular edema; triamcinolone.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )